Drug class refractoriness, not number of prior lines of therapy, properly classify patients with relapsed and refractory multiple myeloma | paper by Luciano J Costa - Upcarta

Mentions

Manni Mohyuddin @ManniMD1 · Jan 18, 2023

From Twitter

Great work, Dr Costa!

Paper

Drug class refractoriness, not number of prior lines of therapy, properly classify patients with relapsed and refractory multiple myeloma

by Luciano J Costa

Recommended by 1 person

1 mention